The ACS Patient Journey: Where Does T2 Diabetes Fit In? - European Medical Journal

The ACS Patient Journey: Where Does T2 Diabetes Fit In?


At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th September 2015, Prof Jean-Claude Tardif of the Montreal Heart Institute Research Centre, Montreal, Quebec, Canada, describes the epidemiology and clinical management of acute coronary syndrome (ACS) patients and how Type 2 diabetes acts as a risk factor for cardiovascular disease.

The treatment of diabetic post-ACS patients is suboptimal, with an increased risk of short and long-term cardiovascular events and higher rates of long-term mortality compared with non-diabetic patients, and requires an individualised, intensive approach.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally